The potential link between PML NBs and ICP0 in regulating lytic and latent infection of HSV-1

Protein and Cell

Volumn 3, Issue 5, 2012, Pages 372-382

  Wang, Shuai ^a   Long, Jing ^a   Zheng, Chun fu ^a  

^a WUHAN INSTITUTE OF VIROLOGY   (China)

Author keywords

herpes simplex virus type 1 (HSV 1); ICP0; promyelocytic leukemia (PML); reactivation; speckled protein of 100 kDa (Sp100)

Indexed keywords

IMMEDIATE EARLY PROTEIN; PROTEIN ICP0; UNCLASSIFIED DRUG;

CELL FUNCTION; CELL NUCLEUS INCLUSION BODY; CELL STRUCTURE; GENE EXPRESSION; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 1; HOST RESISTANCE; HUMAN; IMMUNE RESPONSE; INFECTION RESISTANCE; LATENT VIRUS INFECTION; LYSIS; NONHUMAN; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA NUCLEAR BODY; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY MECHANISM; REVIEW; VIRUS GENOME; VIRUS REPLICATION;

HUMAN HERPESVIRUS 1;

EID: 84861657432     PISSN: 1674800X     EISSN: 16748018     Source Type: Journal    
DOI: 10.1007/s13238-012-2021-x     Document Type: Review

References (131)

1. Ahn, J. H., and Hayward, G. S. (2000). Disruption of PML-associated nuclear bodies by IE1 correlates with efficient early stages of viral gene expression and DNA replication in human cytomegalovirus infection. Virology 274, 39-55.
2. Antón, L. C., Schubert, U., Bacík, I., Princiotta, M. F., Wearsch, P. A., Gibbs, J., Day, P. M., Realini, C., Rechsteiner, M. C., Bennink, J. R., et al. (1999). Intracellular localization of proteasomal degradation of a viral antigen. J Cell Biol 146, 113-124.
3. Aslani, A., Simonsson, S., and Elias, P. (2000). A novel conformation of the herpes simplex virus origin of DNA replication recognized by the origin binding protein. J Biol Chem 275, 5880-5887.
4. Bell, P., Lieberman, P. M., and Maul, G. G. (2000). Lytic but not latent replication of epstein-barr virus is associated with PML and induces sequential release of nuclear domain 10 proteins. J Virol 74, 11800-11810.
5. Bernardi, R., and Pandolfi, P. P. (2003). Role of PML and the PML-nuclear body in the control of programmed cell death. Oncogene 22, 9048-9057.
6. Bischof, O., Kirsh, O., Pearson, M., Itahana, K., Pelicci, P. G., and Dejean, A. (2002). Deconstructing PML-induced premature senescence. EMBO J 21, 3358-3369.
7. Blondel, D., Kheddache, S., Lahaye, X., Dianoux, L., and Chelbi-Alix, M. K. (2010). Resistance to rabies virus infection conferred by the PMLIV isoform. J Virol 84, 10719-10726.
8. Blondel, D., Regad, T., Poisson, N., Pavie, B., Harper, F., Pandolfi, P. P., De Thé, H., and Chelbi-Alix, M. K. (2002). Rabies virus P and small P products interact directly with PML and reorganize PML nuclear bodies. Oncogene 21, 7957-7970.
9. Bonilla, W. V., Pinschewer, D. D., Klenerman, P., Rousson, V., Gaboli, M., Pandolfi, P. P., Zinkernagel, R. M., Salvato, M. S., and Hengartner, H. (2002). Effects of promyelocytic leukemia protein on virus-host balance. J Virol 76, 3810-3818.
10. Boutell, C., and Everett, R. D. (2003). The herpes simplex virus type 1 (HSV-1) regulatory protein ICP0 interacts with and Ubiquitinates p53. J Biol Chem 278, 36596-36602.
11. Boutell, C., Sadis, S., and Everett, R. D. (2002). Herpes simplex virus type 1 immediate-early protein ICP0 and is isolated RING finger domain act as ubiquitin E3 ligases in vitro. J Virol 76, 841-850.
12. Cai, W., Astor, T. L., Liptak, L. M., Cho, C., Coen, D. M., and Schaffer, P. A. (1993). The herpes simplex virus type 1 regulatory protein ICP0 enhances virus replication during acute infection and reactivation from latency. J Virol 67, 7501-7512.
13. Cai, W., and Schaffer, P. A. (1991). A cellular function can enhance gene expression and plating efficiency of a mutant defective in the gene for ICP0, a transactivating protein of herpes simplex virus type 1. J Virol 65, 4078-4090.
14. Cai, W., and Schaffer, P. A. (1992). Herpes simplex virus type 1 ICP0 regulates expression of immediate-early, early, and late genes in productively infected cells. J Virol 66, 2904-2915.
15. Chelbi-Alix, M. K., and de Thé, H. (1999). Herpes virus induced proteasome-dependent degradation of the nuclear bodies-associated PML and Sp100 proteins. Oncogene 18, 935-941.
16. Chelbi-Alix, M. K., Quignon, F., Pelicano, L., Koken, M. H., and de Thé, H. (1998). Resistance to virus infection conferred by the interferon-induced promyelocytic leukemia protein. J Virol 72, 1043-1051.
17. Cuchet-Lourenço, D., Boutell, C., Lukashchuk, V., Grant, K., Sykes, A., Murray, J., Orr, A., and Everett, R. D. (2011). SUMO pathway dependent recruitment of cellular repressors to herpes simplex virus type 1 genomes. PLoS Pathog 7, e1002123.
18. Dellaire, G., and Bazett-Jones, D. P. (2004). PML nuclear bodies: dynamic sensors of DNA damage and cellular stress. Bioessays 26, 963-977.
19. Dellaire, G., Ching, R. W., Ahmed, K., Jalali, F., Tse, K. C., Bristow, R. G., and Bazett-Jones, D. P. (2006). Promyelocytic leukemia nuclear bodies behave as DNA damage sensors whose response to DNA double-strand breaks is regulated by NBS1 and the kinases ATM, Chk2, and ATR. J Cell Biol 175, 55-66.
20. DeLuca, N. A., McCarthy, A. M., and Schaffer, P. A. (1985). Isolation and characterization of deletion mutants of herpes simplex virus type 1 in the gene encoding immediate-early regulatory protein ICP4. J Virol 56, 558-570.
21. Doucas, V., Ishov, A. M., Romo, A., Juguilon, H., Weitzman, M. D., Evans, R. M., and Maul, G. G. (1996). Adenovirus replication is coupled with the dynamic properties of the PML nuclear structure. Genes Dev 10, 196-207.
22. Duprez, E., Saurin, A. J., Desterro, J. M., Lallemand-Breitenbach, V., Howe, K., Boddy, M. N., Solomon, E., de Thé, H., Hay, R. T., and Freemont, P. S. (1999). SUMO-1 modification of the acute promyelocytic leukaemia protein PML: implications for nuclear localisation. J Cell Sci 112, 381-393.
23. Efstathiou, S., and Preston, C. M. (2005). Towards an understanding of the molecular basis of herpes simplex virus latency. Virus Res 111, 108-119.
24. El McHichi, B., Regad, T., Maroui, M. A., Rodriguez, M. S., Aminev, A., Gerbaud, S., Escriou, N., Dianoux, L., and Chelbi-Alix, M. K. (2010). SUMOylation promotes PML degradation during encephalomyocarditis virus infection. J Virol 84, 11634-11645.
25. Everett, R. D. (1988). Analysis of the functional domains of herpes simplex virus type 1 immediate-early polypeptide Vmw110. J Mol Biol 202, 87-96.
26. Everett, R. D. (1989). Construction and characterization of herpes simplex virus type 1 mutants with defined lesions in immediate early gene 1. J Gen Virol 70, 1185-1202.
27. Everett, R. D. (2000). ICP0, a regulator of herpes simplex virus during lytic and latent infection. Bioessays 22, 761-770.
28. Everett, R. D. (2001). DNA viruses and viral proteins that interact with PML nuclear bodies. Oncogene 20, 7266-7273.
29. Everett, R. D. (2006). Interactions between DNA viruses, ND10 and the DNA damage response. Cell Microbiol 8, 365-374.
30. Everett, R. D., Boutell, C., and Orr, A. (2004a). Phenotype of a herpes simplex virus type 1 mutant that fails to express immediate-early regulatory protein ICP0. J Virol 78, 1763-1774.
31. Everett, R. D., and Chelbi-Alix, M. K. (2007). PML and PML nuclear bodies: implications in antiviral defence. Biochimie 89, 819-830.
32. Everett, R. D., Earnshaw, W. C., Findlay, J., and Lomonte, P. (1999a). Specific destruction of kinetochore protein CENP-C and disruption of cell division by herpes simplex virus immediate-early protein Vmw110. EMBO J 18, 1526-1538.
33. Everett, R. D., Freemont, P., Saitoh, H., Dasso, M., Orr, A., Kathoria, M., and Parkinson, J. (1998a). The disruption of ND10 during herpes simplex virus infection correlates with the Vmw110- and proteasome-dependent loss of several PML isoforms. J Virol 72, 6581-6591.
34. Everett, R. D., Lomonte, P., Sternsdorf, T., van Driel, R., and Orr, A. (1999b). Cell cycle regulation of PML modification and ND10 composition. J Cell Sci 112, 4581-4588.
35. Everett, R. D., and Maul, G. G. (1994). HSV-1 IE protein Vmw110 causes redistribution of PML. EMBO J 13, 5062-5069.
36. Everett, R. D., Meredith, M., Orr, A., Cross, A., Kathoria, M., and Parkinson, J. (1997). A novel ubiquitin-specific protease is dynamically associated with the PML nuclear domain and binds to a herpesvirus regulatory protein. EMBO J 16, 566-577.
37. Everett, R. D., and Murray, J. (2005). ND10 components relocate to sites associated with herpes simplex virus type 1 nucleoprotein complexes during virus infection. J Virol 79, 5078-5089.
38. Everett, R. D., Murray, J., Orr, A., and Preston, C. M. (2007). Herpes simplex virus type 1 genomes are associated with ND10 nuclear substructures in quiescently infected human fibroblasts. J Virol 81, 10991-11004.
39. Everett, R. D., Orr, A., and Preston, C. M. (1998b). A viral activator of gene expression functions via the ubiquitin-proteasome pathway. EMBO J 17, 7161-7169.
40. Everett, R. D., Parada, C., Gripon, P., Sirma, H., and Orr, A. (2008a). Replication of ICP0-null mutant herpes simplex virus type 1 is restricted by both PML and Sp100. J Virol 82, 2661-2672.
41. Everett, R. D., Rechter, S., Papior, P., Tavalai, N., Stamminger, T., and Orr, A. (2006). PML contributes to a cellular mechanism of repression of herpes simplex virus type 1 infection that is inactivated by ICP0. J Virol 80, 7995-8005.
42. Everett, R. D., Sourvinos, G., Leiper, C., Clements, J. B., and Orr, A. (2004b). Formation of nuclear foci of the herpes simplex virus type 1 regulatory protein ICP4 at early times of infection: localization, dynamics, recruitment of ICP27, and evidence for the de novo induction of ND10-like complexes. J Virol 78, 1903-1917.
43. Everett, R. D., Young, D. F., Randall, R. E., and Orr, A. (2008b). STAT-1- and IRF-3-dependent pathways are not essential for repression of ICP0-null mutant herpes simplex virus type 1 in human fibroblasts. J Virol 82, 8871-8881.
44. Ferenczy, M. W., and DeLuca, N. A. (2011). Reversal of heterochromatic silencing of quiescent herpes simplex virus type 1 by ICP0. J Virol 85, 3424-3435.
45. Fraefel, C., Bittermann, A. G., Büeler, H., Heid, I., Bächi, T., and Ackermann, M. (2004). Spatial and temporal organization of adeno-associated virus DNA replication in live cells. J Virol 78, 389-398.
46. Fukuyo, Y., Horikoshi, N., Ishov, A. M., Silverstein, S. J., and Nakajima, T. (2011). The herpes simplex virus immediate-early ubiquitin ligase ICP0 induces degradation of the ICP0 repressor protein E2FBP1. J Virol 85, 3356-3366.
47. Fukuyo, Y., Mogi, K., Tsunematsu, Y., and Nakajima, T. (2004). E2FBP1/hDril1 modulates cell growth through downregulation of promyelocytic leukemia bodies. Cell Death Differ 11, 747-759.
48. Gresko, E., Ritterhoff, S., Sevilla-Perez, J., Roscic, A., Fröbius, K., Kotevic, I., Vichalkovski, A., Hess, D., Hemmings, B. A., and Schmitz, M. L. (2009). PML tumor suppressor is regulated by HIPK2-mediated phosphorylation in response to DNA damage. Oncogene 28, 698-708.
49. Gu, H., and Roizman, B. (2003). The degradation of promyelocytic leukemia and Sp100 proteins by herpes simplex virus 1 is mediated by the ubiquitin-conjugating enzyme UbcH5a. Proc Natl Acad Sci U S A 100, 8963-8968.
50. Hagglund, R., and Roizman, B. (2002). Characterization of the novel E3 ubiquitin ligase encoded in exon 3 of herpes simplex virus-1-infected cell protein 0. Proc Natl Acad Sci U S A 99, 7889-7894.
51. Hagglund, R., and Roizman, B. (2003). Herpes simplex virus 1 mutant in which the ICP0 HUL-1 E3 ubiquitin ligase site is disrupted stabilizes cdc34 but degrades D-type cyclins and exhibits diminished neurotoxicity. J Virol 77, 13194-13202.
52. Hagglund, R., and Roizman, B. (2004). Role of ICP0 in the strategy of conquest of the host cell by herpes simplex virus 1. J Virol 78, 2169-2178.
53. Hagglund, R., van Sant, C., Lopez, P., and Roizman, B. (2002). Herpes simplex virus 1-infected cell protein 0 contains two E3 ubiquitin ligase sites specific for different E2 ubiquitin-conjugating enzymes. Proc Natl Acad Sci U S A 99, 631-636.
54. Halford, W. P., Kemp, C. D., Isler, J. A., Davido, D. J., and Schaffer, P. A. (2001). ICP0, ICP4, or VP16 expressed from adenovirus vectors induces reactivation of latent herpes simplex virus type 1 in primary cultures of latently infected trigeminal ganglion cells. J Virol 75, 6143-6153.
55. Halford, W. P., and Schaffer, P. A. (2001). ICP0 is required for efficient reactivation of herpes simplex virus type 1 from neuronal latency. J Virol 75, 3240-3249.
56. Harris, R. A., and Preston, C. M. (1991). Establishment of latency in vitro by the herpes simplex virus type 1 mutant in1814. J Gen Virol 72, 907-913.
57. Herrera, F. J., and Triezenberg, S. J. (2004). VP16-dependent association of chromatin-modifying coactivators and underrepresentation of histones at immediate-early gene promoters during herpes simplex virus infection. J Virol 78, 9689-9696.
58. Iki, S., Yokota, S., Okabayashi, T., Yokosawa, N., Nagata, K., and Fujii, N. (2005). Serum-dependent expression of promyelocytic leukemia protein suppresses propagation of influenza virus. Virology 343, 106-115.
59. Ishov, A. M., and Maul, G. G. (1996). The periphery of nuclear domain 10 (ND10) as site of DNA virus deposition. J Cell Biol 134, 815-826.
60. Ishov, A. M., Sotnikov, A. G., Negorev, D., Vladimirova, O. V., Neff, N., Kamitani, T., Yeh, E. T., Strauss, J. F. 3rd, and Maul, G. G. (1999). PML is critical for ND10 formation and recruits the PML-interacting protein daxx to this nuclear structure when modified by SUMO-1. J Cell Biol 147, 221-234.
61. Ishov, A. M., Stenberg, R. M., and Maul, G. G. (1997). Human cytomegalovirus immediate early interaction with host nuclear structures: definition of an immediate transcript environment. J Cell Biol 138, 5-16.
62. Jackson, S. A., and DeLuca, N. A. (2003). Relationship of herpes simplex virus genome configuration to productive and persistent infections. Proc Natl Acad Sci U S A 100, 7871-7876.
63. Jul-Larsen, A., Visted, T., Karlsen, B. O., Rinaldo, C. H., Bjerkvig, R., Lønning, P. E., and Bøe, S. O. (2004). PML-nuclear bodies accumulate DNA in response to polyomavirus BK and simian virus 40 replication. Exp Cell Res 298, 58-73.
64. Kamitani, T., Kito, K., Nguyen, H. P., Wada, H., Fukuda-Kamitani, T., and Yeh, E. T. (1998a). Identification of three major sentrinization sites in PML. J Biol Chem 273, 26675-26682.
65. Kamitani, T., Nguyen, H. P., Kito, K., Fukuda-Kamitani, T., and Yeh, E. T. (1998b). Covalent modification of PML by the sentrin family of ubiquitin-like proteins. J Biol Chem 273, 3117-3120.
66. Kawaguchi, Y., Bruni, R., and Roizman, B. (1997a). Interaction of herpes simplex virus 1 alpha regulatory protein ICP0 with elongation factor 1delta: ICP0 affects translational machinery. J Virol 71, 1019-1024.
67. Kawaguchi, Y., Tanaka, M., Yokoymama, A., Matsuda, G., Kato, K., Kagawa, H., Hirai, K., and Roizman, B. (2001). Herpes simplex virus 1 alpha regulatory protein ICP0 functionally interacts with cellular transcription factor BMAL1. Proc Natl Acad Sci U S A 98, 1877-1882.
68. Kawaguchi, Y., van Sant, C., and Roizman, B. (1997b). Herpes simplex virus 1 alpha regulatory protein ICP0 interacts with and stabilizes the cell cycle regulator cyclin D3. J Virol 71, 7328-7336.
69. Klemm, R. D., Goodrich, J. A., Zhou, S., and Tjian, R. (1995). Molecular cloning and expression of the 32-kDa subunit of human TFIID reveals interactions with VP16 and TFIIB that mediate transcriptional activation. Proc Natl Acad Sci U S A 92, 5788-5792.
70. Kyratsous, C. A., and Silverstein, S. J. (2009). Components of nuclear domain 10 bodies regulate varicella-zoster virus replication. J Virol 83, 4262-4274.
71. Lallemand-Breitenbach, V., Zhu, J., Puvion, F., Koken, M., Honoré, N., Doubeikovsky, A., Duprez, E., Pandolfi, P. P., Puvion, E., Freemont, P., et al. (2001). Role of promyelocytic leukemia (PML) sumolation in nuclear body formation, 11S proteasome recruitment, and As2O3-induced PML or PML/retinoic acid receptor alpha degradation. J Exp Med 193, 1361-1371.
72. Lees-Miller, S. P., Long, M. C., Kilvert, M. A., Lam, V., Rice, S. A., and Spencer, C. A. (1996). Attenuation of DNA-dependent protein kinase activity and its catalytic subunit by the herpes simplex virus type 1 transactivator ICP0. J Virol 70, 7471-7477.
73. Lehman, I. R., and Boehmer, P. E. (1999). Replication of herpes simplex virus DNA. J Biol Chem 274, 28059-28062.
74. Leib, D. A., Coen, D. M., Bogard, C. L., Hicks, K. A., Yager, D. R., Knipe, D. M., Tyler, K. L., and Schaffer, P. A. (1989). Immediate-early regulatory gene mutants define different stages in the establishment and reactivation of herpes simplex virus latency. J Virol 63, 759-768.
75. Li, W., Wang, G., Zhang, H., Zhang, D., Zeng, J., Chen, X., Xu, Y., and Li, K. (2009). Differential suppressive effect of promyelocytic leukemia protein on the replication of different subtypes/strains of influenza A virus. Biochem Biophys Res Commun 389, 84-89.
76. Ling, P. D., Peng, R. S., Nakajima, A., Yu, J. H., Tan, J., Moses, S. M., Yang, W. H., Zhao, B., Kieff, E., Bloch, K. D., et al. (2005). Mediation of Epstein-Barr virus EBNA-LP transcriptional coactivation by Sp100. EMBO J 24, 3565-3575.
77. Lomonte, P., and Morency, E. (2007). Centromeric protein CENP-B proteasomal degradation induced by the viral protein ICP0. FEBS Lett 581, 658-662.
78. Lomonte, P., Sullivan, K. F., and Everett, R. D. (2001). Degradation of nucleosome-associated centromeric histone H3-like protein CENP-A induced by herpes simplex virus type 1 protein ICP0. J Biol Chem 276, 5829-5835.
79. Lomonte, P., Thomas, J., Texier, P., Caron, C., Khochbin, S., and Epstein, A. L. (2004). Functional interaction between class II histone deacetylases and ICP0 of herpes simplex virus type 1. J Virol 78, 6744-6757.
80. Lopez, P., Jacob, R. J., and Roizman, B. (2002). Overexpression of promyelocytic leukemia protein precludes the dispersal of ND10 structures and has no effect on accumulation of infectious herpes simplex virus 1 or its proteins. J Virol 76, 9355-9367.
81. Lukashchuk, V., and Everett, R. D. (2010). Regulation of ICP0-null mutant herpes simplex virus type 1 infection by ND10 components ATRX and hDaxx. J Virol 84, 4026-4040.
82. Mahajan, S. S., Little, M. M., Vazquez, R., and Wilson, A. C. (2002). Interaction of HCF-1 with a cellular nuclear export factor. J Biol Chem 277, 44292-44299.
83. Maul, G. G. (1998). Nuclear domain 10, the site of DNA virus transcription and replication. Bioessays 20, 660-667.
84. Maul, G. G., and Everett, R. D. (1994). The nuclear location of PML, a cellular member of the C3HC4 zinc-binding domain protein family, is rearranged during herpes simplex virus infection by the C3HC4 viral protein ICP0. J Gen Virol 75, 1223-1233.
85. Maul, G. G., Guldner, H. H., and Spivack, J. G. (1993). Modification of discrete nuclear domains induced by herpes simplex virus type 1 immediate early gene 1 product (ICP0). J Gen Virol 74, 2679-2690.
86. Maul, G. G., Ishov, A. M., and Everett, R. D. (1996). Nuclear domain 10 as preexisting potential replication start sites of herpes simplex virus type-1. Virology 217, 67-75.
87. McNally, B. A., Trgovcich, J., Maul, G. G., Liu, Y., and Zheng, P. (2008). A role for cytoplasmic PML in cellular resistance to viral infection. PLoS One 3, e2277.
88. Memedula, S., and Belmont, A. S. (2003). Sequential recruitment of HAT and SWI/SNF components to condensed chromatin by VP16. Curr Biol 13, 241-246.
89. Meredith, M., Orr, A., Elliott, M., and Everett, R. (1995). Separation of sequence requirements for HSV-1 Vmw110 multimerisation and interaction with a 135-kDa cellular protein. Virology 209, 174-187.
90. Mitchell, B. M., Bloom, D. C., Cohrs, R. J., Gilden, D. H., and Kennedy, P. G. (2003). Herpes simplex virus-1 and varicella-zoster virus latency in ganglia. J Neurovirol 9, 194-204.
91. Mittler, G., Stühler, T., Santolin, L., Uhlmann, T., Kremmer, E., Lottspeich, F., Berti, L., and Meisterernst, M. (2003). A novel docking site on Mediator is critical for activation by VP16 in mammalian cells. EMBO J 22, 6494-6504.
92. Mossman, K. L., and Smiley, J. R. (2002). Herpes simplex virus ICP0 and ICP34. 5 counteract distinct interferon-induced barriers to virus replication. J Virol 76, 1995-1998.
93. Müller, S., Matunis, M. J., and Dejean, A. (1998). Conjugation with the ubiquitin-related modifier SUMO-1 regulates the partitioning of PML within the nucleus. EMBO J 17, 61-70.
94. Negorev, D., and Maul, G. G. (2001). Cellular proteins localized at and interacting within ND10/PML nuclear bodies/PODs suggest functions of a nuclear depot. Oncogene 20, 7234-7242.
95. Negorev, D. G., Vladimirova, O. V., Ivanov, A., Rauscher, F. 3rd, and Maul, G. G. (2006). Differential role of Sp100 isoforms in interferon-mediated repression of herpes simplex virus type 1 immediate-early protein expression. J Virol 80, 8019-8029.
96. Negorev, D. G., Vladimirova, O. V., and Maul, G. G. (2009). Differential functions of interferon-upregulated Sp100 isoforms: herpes simplex virus type 1 promoter-based immediate-early gene suppression and PML protection from ICP0-mediated degradation. J Virol 83, 5168-5180.
97. Pampin, M., Simonin, Y., Blondel, B., Percherancier, Y., and Chelbi-Alix, M. K. (2006). Cross talk between PML and p53 during poliovirus infection: implications for antiviral defense. J Virol 80, 8582-8592.
98. Parkinson, J., and Everett, R. D. (2000). Alphaherpesvirus proteins related to herpes simplex virus type 1 ICP0 affect cellular structures and proteins. J Virol 74, 10006-10017.
99. Parkinson, J., Lees-Miller, S. P., and Everett, R. D. (1999). Herpes simplex virus type 1 immediate-early protein vmw110 induces the proteasome-dependent degradation of the catalytic subunit of DNA-dependent protein kinase. J Virol 73, 650-657.
100. Paterson, T., and Everett, R. D. (1988). Mutational dissection of the HSV-1 immediate-early protein Vmw175 involved in transcriptional transactivation and repression. Virology 166, 186-196.
101. Preston, C. M. (2000). Repression of viral transcription during herpes simplex virus latency. J Gen Virol 81, 1-19.
102. Preston, C. M., and Nicholl, M. J. (1997). Repression of gene expression upon infection of cells with herpes simplex virus type 1 mutants impaired for immediate-early protein synthesis. J Virol 71, 7807-7813.
103. Regad, T., and Chelbi-Alix, M. K. (2001). Role and fate of PML nuclear bodies in response to interferon and viral infections. Oncogene 20, 7274-7286.
104. Regad, T., Saib, A., Lallemand-Breitenbach, V., Pandolfi, P. P., de Thé, H., and Chelbi-Alix, M. K. (2001). PML mediates the interferon-induced antiviral state against a complex retrovirus via its association with the viral transactivator. EMBO J 20, 3495-3505.
105. Reichelt, M., Wang, L., Sommer, M., Perrino, J., Nour, A. M., Sen, N., Baiker, A., Zerboni, L., and Arvin, A. M. (2011). Entrapment of viral capsids in nuclear PML cages is an intrinsic antiviral host defense against varicella-zoster virus. PLoS Pathog 7, e1001266.
106. Rolley, N., Butcher, S., and Milner, J. (1995). Specific DNA binding by different classes of human p53 mutants. Oncogene 11, 763-770.
107. Sacks, W. R., and Schaffer, P. A. (1987). Deletion mutants in the gene encoding the herpes simplex virus type 1 immediate-early protein ICP0 exhibit impaired growth in cell culture. J Virol 61, 829-839.
108. Saffert, R. T., and Kalejta, R. F. (2008). Promyelocytic leukemia-nuclear body proteins: herpesvirus enemies, accomplices, or both? Future Virol 3, 265-277.
109. Samaniego, L. A., Neiderhiser, L., and DeLuca, N. A. (1998). Persistence and expression of the herpes simplex virus genome in the absence of immediate-early proteins. J Virol 72, 3307-3320.
110. Schreiner, S., Wimmer, P., Sirma, H., Everett, R. D., Blanchette, P., Groitl, P., and Dobner, T. (2010). Proteasome-dependent degradation of Daxx by the viral E1B-55K protein in human adenovirus-infected cells. J Virol 84, 7029-7038.
111. Seeler, J. S., and Dejean, A. (2001). SUMO: of branched proteins and nuclear bodies. Oncogene 20, 7243-7249.
112. Shen, T. H., Lin, H. K., Scaglioni, P. P., Yung, T. M., and Pandolfi, P. P. (2006). The mechanisms of PML-nuclear body formation. Mol Cell 24, 331-339.
113. Shimomura Y. (2008). Herpes simplex virus latency, reactivation, and a new antiviral therapy for herpetic keratitis. Nihon Ganka Gakkai Zasshi 112, 247-264; discussion 265.
114. Smith, A. E., and Helenius, A. (2004). How viruses enter animal cells. Science 304, 237-242.
115. Smith, C. A., Bates, P., Rivera-Gonzalez, R., Gu, B., and DeLuca, N. A. (1993). ICP4, the major transcriptional regulatory protein of herpes simplex virus type 1, forms a tripartite complex with TATA-binding protein and TFIIB. J Virol 67, 4676-4687.
116. Sternsdorf, T., Grötzinger, T., Jensen, K., and Will, H. (1997a). Nuclear dots: actors on many stages. Immunobiology 198, 307-331.
117. Sternsdorf, T., Jensen, K., Reich, B., and Will, H. (1999). The nuclear dot protein sp100, characterization of domains necessary for dimerization, subcellular localization, and modification by small ubiquitin-like modifiers. J Biol Chem 274, 12555-12566.
118. Sternsdorf, T., Jensen, K., and Will, H. (1997b). Evidence for covalent modification of the nuclear dot-associated proteins PML and Sp100 by PIC1/SUMO-1. J Cell Biol 139, 1621-1634.
119. Stow, N. D., and Stow, E. C. (1986). Isolation and characterization of a herpes simplex virus type 1 mutant containing a deletion within the gene encoding the immediate early polypeptide Vmw110. J Gen Virol 67, 2571-2585.
120. Tavalai, N., Papior, P., Rechter, S., Leis, M., and Stamminger, T. (2006). Evidence for a role of the cellular ND10 protein PML in mediating intrinsic immunity against human cytomegalovirus infections. J Virol 80, 8006-8018.
121. Tavalai, N., Papior, P., Rechter, S., and Stamminger, T. (2008). Nuclear domain 10 components promyelocytic leukemia protein and hDaxx independently contribute to an intrinsic antiviral defense against human cytomegalovirus infection. J Virol 82, 126-137.
122. Tavalai, N., and Stamminger, T. (2008). New insights into the role of the subnuclear structure ND10 for viral infection. Biochim Biophys Acta 1783, 2207-2221.
123. van Sant, C., Hagglund, R., Lopez, P., and Roizman, B. (2001). The infected cell protein 0 of herpes simplex virus 1 dynamically interacts with proteasomes, binds and activates the cdc34 E2 ubiquitin-conjugating enzyme, and possesses in vitro E3 ubiquitin ligase activity. Proc Natl Acad Sci U S A 98, 8815-8820.
124. von Einem, J., Schumacher, D., O'Callaghan, D. J., and Osterrieder, N. (2006). The alpha-TIF (VP16) homologue (ETIF) of equine herpesvirus 1 is essential for secondary envelopment and virus egress. J Virol 80, 2609-2620.
125. Wagner, E. K., and Bloom, D. C. (1997). Experimental investigation of herpes simplex virus latency. Clin Microbiol Rev 10, 419-443.
126. Watson, R. J., and Clements, J. B. (1980). A herpes simplex virus type 1 function continuously required for early and late virus RNA synthesis. Nature 285, 329-330.
127. Wiesmeijer, K., Molenaar, C., Bekeer, I. M., Tanke, H. J., and Dirks, R. W. (2002). Mobile foci of Sp100 do not contain PML: PML bodies are immobile but PML and Sp100 proteins are not. J Struct Biol 140, 180-188.
128. Wysocka, J., and Herr, W. (2003). The herpes simplex virus VP16-induced complex: the makings of a regulatory switch. Trends Biochem Sci 28, 294-304.
129. Xiao, H., Pearson, A., Coulombe, B., Truant, R., Zhang, S., Regier, J. L., Triezenberg, S. J., Reinberg, D., Flores, O., Ingles, C. J., et al. (1994). Binding of basal transcription factor TFIIH to the acidic activation domains of VP16 and p53. Mol Cell Biol 14, 7013-7024.
130. Yao, F., and Schaffer, P. A. (1995). An activity specified by the osteosarcoma line U2OS can substitute functionally for ICP0, a major regulatory protein of herpes simplex virus type 1. J Virol 69, 6249-6258.
131. Zhong, S., Müller, S., Ronchetti, S., Freemont, P. S., Dejean, A., and Pandolfi, P. P. (2000). Role of SUMO-1-modified PML in nuclear body formation. Blood 95, 2748-2752.